Development of new targeted therapies for breast cancer

Cancer Treat Res. 2008:141:119-34. doi: 10.1007/978-0-387-73161-2_8.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • ErbB Receptors / antagonists & inhibitors
  • Female
  • Humans
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Receptor, ErbB-2 / metabolism
  • Signal Transduction
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • ErbB Receptors
  • Protein-Tyrosine Kinases
  • Receptor, ErbB-2
  • Trastuzumab